3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostatic Neoplasms
1
Lymphoma, Follicular
1
Hypertension
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Interventions
fludarabine phosphate
15
Cyclophosphamide
15
Peripheral Blood Stem Cell Transplantation
13
Cyclosporine
12
Whole-Body Irradiation
10
Filgrastim
10
Mycophenolic Acid
9
Busulfan
8
Antilymphocyte Serum
7
Radiotherapy
5
Methylprednisolone
5
Melphalan
5
Therapeutics
4
Psychiatric Rehabilitation
4
Methotrexate
4
Exercise
4
Etoposide
4
Cord Blood Stem Cell Transplantation
4
Blood Specimen Collection
4
fludarabine
3
Rituximab
3
Prednisone
3
Granulocyte Colony-Stimulating Factor
3
Dexamethasone
3
Aprepitant
3
Analgesia
3
plerixafor
2
Tacrolimus
2
Standard of Care
2
Ondansetron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, Follicular
×
Angiotensin-Converting Enzyme Inhibitors
×
Clear all
NCT01258764
2015-05-20
1HAT
Scripps Translational Science Institute
Phase NA
Completed
2 enrolled